Works matching DE "MONOCLONAL antibodies"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis).

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 6, p. 1427, doi. 10.1007/s13555-025-01416-z
    By:
    • Valenti, Mario;
    • Ibba, Luciano;
    • Di Giulio, Sara;
    • Gargiulo, Luigi;
    • Malagoli, Piergiorgio;
    • Balato, Anna;
    • Bardazzi, Federico;
    • Loconsole, Francesco;
    • Burlando, Martina;
    • Cagni, Anna E.;
    • Cameli, Norma;
    • Carrera, Carlo G.;
    • Carugno, Andrea;
    • Cuccia, Aldo;
    • Dapavo, Paolo;
    • Di Brizzi, Eugenia V.;
    • Dini, Valentina;
    • Fargnoli, Maria C.;
    • Gaiani, Francesca M.;
    • Guarneri, Claudio
    Publication type:
    Article
    14
    15
    16
    17
    18

    IQ Survey Results on Current Industry Practices—Part 1: Immunogenicity Risk Assessment.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1596, doi. 10.1002/cpt.3568
    By:
    • Grimaldi, Christine;
    • Richards, Susan;
    • Baltrukonis, Daniel;
    • Sims Belouski, Shelley;
    • Coble, Kelly;
    • Dholakiya, Sanjay L.;
    • Grudzinska‐Goebel, Joanna;
    • Kolaitis, Gerry;
    • Leu, Jocelyn H.;
    • Luo, Linlin;
    • Lowe, Stephen;
    • Niu, Tao;
    • Toft‐Hansen, Henrik;
    • Yang, Jianning;
    • Wu, Benjamin
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

    Published in:
    Cancers, 2025, v. 17, n. 9, p. 1443, doi. 10.3390/cancers17091443
    By:
    • Zehentmayr, Franz;
    • Feurstein, Petra;
    • Ruznic, Elvis;
    • Langer, Brigitte;
    • Grambozov, Brane;
    • Klebermass, Marisa;
    • Hochreiter, Alexandra;
    • Purevdorj, Ayurzana;
    • Gruber, Georg;
    • Minasch, Danijela;
    • Breitfelder, Barbara;
    • Steffal, Claudia;
    • Kirchhammer, Karoline;
    • Stranzl, Heidi;
    • Röder, Falk;
    • Dieckmann, Karin
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Axatilimab.

    Published in:
    Hospital Pharmacy, 2025, v. 60, n. 3, p. 202, doi. 10.1177/00185787241310874
    By:
    • Levien, Terri L.;
    • Baker, Danial E.
    Publication type:
    Article
    49
    50

    Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products -- United States, October 2024-February 2025.

    Published in:
    MMWR: Morbidity & Mortality Weekly Report, 2025, v. 74, n. 16, p. 273, doi. 10.15585/mmwr.mm7416a1
    By:
    • Patton, Monica E.;
    • Moline, Heidi L.;
    • Whitaker, Michael;
    • Tannis, Ayzsa;
    • Huong Pham;
    • Toepfer, Ariana P.;
    • Taylor, Christopher A.;
    • Goldstein, Leah;
    • Reingold, Arthur;
    • Kirley, Pam Daily;
    • Alden, Nisha B.;
    • Kawasaki, Breanna;
    • Meek, James;
    • Daewi Kim;
    • Witt, Lucy S.;
    • Openo, Kyle P.;
    • Ryan, Patricia A.;
    • Mumm, Erica;
    • Lynfield, Ruth;
    • Salazar-Sanchez, Yadira
    Publication type:
    Article